Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M, d'Amore F, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E. Krogh-Jensen M, et al. Among authors: jensen mk. Ann Oncol. 1994 Apr;5(4):349-54. doi: 10.1093/oxfordjournals.annonc.a058839. Ann Oncol. 1994. PMID: 8075032 Free article.
Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M, D'Amore F, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E. Krogh-Jensen M, et al. Among authors: jensen mk. Leuk Lymphoma. 1995 Oct;19(3-4):223-33. doi: 10.3109/10428199509107892. Leuk Lymphoma. 1995. PMID: 8535213
Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
d'Amore F, Brincker H, Grønbaek K, Thorling K, Pedersen M, Jensen MK, Andersen E, Pedersen NT, Mortensen LS. d'Amore F, et al. Among authors: jensen mk. J Clin Oncol. 1994 Aug;12(8):1673-84. doi: 10.1200/JCO.1994.12.8.1673. J Clin Oncol. 1994. PMID: 8040680
[Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK, d'Amore FA, Jensen MK, Christensen BE, Thorling K, Pedersen M, Johansen P, Boesen AM, Andersen E. Jensen MK, et al. Ugeskr Laeger. 1996 Jul 29;158(31):4406-12. Ugeskr Laeger. 1996. PMID: 8759999 Danish.
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.
de Nully Brown P, Hoffmann T, Hansen OP, Boesen AM, Grønbaek K, Hippe E, Jensen MK, Thorling K, Storm HH, Pedersen-Bjergaard J. de Nully Brown P, et al. Among authors: jensen mk. Leukemia. 1997 Jan;11(1):37-41. doi: 10.1038/sj.leu.2400514. Leukemia. 1997. PMID: 9001416 Clinical Trial.
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
Nissen NI, Nordentoft AM, Brincker H, Andersen E, Jensen MK, Nielsen JB, Pedersen-Bjergaard J, Jensen TS, Jensen KB, Videbaek A, Pedersen M, Walbom-Jørgensen S. Nissen NI, et al. Among authors: jensen kb, jensen mk, jensen ts. Scand J Haematol. 1980 Jul;25(1):35-44. doi: 10.1111/j.1600-0609.1981.tb01362.x. Scand J Haematol. 1980. PMID: 7003700 Clinical Trial.
533 results